NS Pharma
September 9, 2026 |
NS Pharma is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd., committed to advancing revolutionary rare disease therapies that address unmet needs and help people live happier, healthier lives.
We serve as an in-house research center of excellence, as well as a first-class commercialization partner to clinical-stage biotechnology companies, driving life-changing scientific innovation forward.